Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of circulating epinephrine on platelet function and hematocrit

S E Kjeldsen1, A B Weder, B Egan

  • 1Department of Internal Medicine, Ullevaal University Hospital, Oslo, Norway.

Hypertension (Dallas, Tex. : 1979)
|May 1, 1995
PubMed
Summary

Raising epinephrine levels in healthy men increased platelet count and weight, but decreased in vitro aggregation. Platelets may self-regulate against excessive epinephrine stimulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to: "Pilot study of on-treatment platelet reactivity at low shear stress and platelet activation status on aspirin or clopidogrel monotherapy in patients with TIA or ischaemic stroke" [JNS 2025 Vol 475, 123540].

Journal of the neurological sciences·2025
Same author

Pilot study of on-treatment platelet reactivity at low shear stress and platelet activation status on aspirin or clopidogrel monotherapy in patients with TIA or ischaemic stroke.

Journal of the neurological sciences·2025
Same author

von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.

Journal of the neurological sciences·2024
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke.

Journal of the neurological sciences·2022

Area of Science:

  • Physiology
  • Hematology

Background:

  • Epinephrine (adrenaline) is a key stress hormone.
  • Its effects on platelet function and hematocrit require further elucidation, particularly at pathophysiological concentrations.

Purpose of the Study:

  • To investigate the impact of controlled, low-range increases in arterial plasma epinephrine on platelet function and hematocrit in healthy men.

Main Methods:

  • Healthy men (20-40 years) received stepwise intravenous epinephrine infusions over 60 minutes.
  • Platelet count, size, aggregation, and hematocrit were measured using different anticoagulants (EDTA, ACD).

Main Results:

  • Epinephrine infusion significantly increased platelet count and weight, with differences observed between EDTA and ACD anticoagulated blood, suggesting in vivo microaggregation or ex vivo adhesion.

Related Experiment Videos

  • In vitro platelet aggregation induced by epinephrine decreased post-infusion, indicating selective downregulation of epinephrine-mediated activation.
  • Hematocrit significantly increased, while platelet sodium-proton exchange and granular content release remained unchanged.

    • Conclusions:

    • Platelets may possess a protective mechanism against epinephrine overstimulation under acute conditions.
    • Epinephrine significantly impacts platelet dynamics and hematocrit, with potential implications for cardiovascular health.
    • Sodium-proton exchange is not implicated in regulating epinephrine's effects on platelet function.